Skip to main content
. 2021 Sep 28;8(6):5316–5326. doi: 10.1002/ehf2.13621

Figure 1.

Figure 1

Study flow chart detailing the inclusion and exclusion criteria for the study patients. The enrolled patients were divided into two groups based on the presence or absence of cardiovascular death. ATTRwt‐CM, wild‐type transthyretin amyloid cardiomyopathy; TTE, transthoracic echocardiography.